Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
BACKGROUND: Primaquine is the only licensed antimalarial for the radical cure of Plasmodium vivax infections. Many countries, however, do not administer primaquine due to fear of hemolysis in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In other settings, primaquine is given witho...
Prif Awduron: | Devine, A, Parmiter, M, Chu, C, Bancone, G, Nosten, F, Price, R, Lubell, Y, Yeung, S |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Public Library of Science
2017
|
Eitemau Tebyg
-
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
gan: Angela Devine, et al.
Cyhoeddwyd: (2017-05-01) -
A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border
gan: Ansari, AT, et al.
Cyhoeddwyd: (2025) -
A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border
gan: April T. Ansari, et al.
Cyhoeddwyd: (2025-01-01) -
A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border.
gan: April T Ansari, et al.
Cyhoeddwyd: (2025-01-01) -
Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar.
gan: Yuan, L, et al.
Cyhoeddwyd: (2014)